|
TCRT Alaunos Therapeutics Inc 1107421 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-952,000.00 |
| Balance Sheet |
|
Current Assets
|
$666,000.00 |
|
Assets
|
$1,516,000.00 |
|
Current Liabilities
|
$864,000.00 |
|
Liabilities
|
$864,000.00 |
|
Equity
|
$652,000.00 |
|
Shares Out
|
2486140.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,331,000.00 |
|
Investing Cash Flow
|
$-98,000.00 |
| Market Analysis |
Market Cap
|
$4,475,052.00 |
|
Price
|
$1.80 |
|
BVPS
|
0.26 |
|
PB
|
6.92 |
|
EPS
|
-0.41 |
|
FCF
|
$-1,429,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRT documents filed with the SEC.
TCRT Filings
Clear
